| 124 Structure of a eukaryotic voltage-gated sodium channel at near-atomic resolution.
123 Crystal Structure of an LSD-Bound Human Serotonin Receptor.
122 Principles for designing proteins with cavities formed by curved β sheets.
121 Crystal structure of unlinked NS2B-NS3 protease from Zika virus.
120 Atomic model for the membrane-embedded VO motor of a eukaryotic V-ATPase.
119 X-ray structure of the human α4β2 nicotinic receptor.
118 Structural basis for inhibition of a voltage-gated Ca2+ channel by Ca2+ antagonist drugs.
117 Structure of the STRA6 receptor for retinol uptake.
116 Structure of mammalian respiratory complex I.
115 Crystal structure of Zika virus NS2B-NS3 protease in complex with a boronate inhibitor.
114 Crystal structure of the epithelial calcium channel TRPV6.
113 Extra-helical binding site of a glucagon receptor antagonist.
112 The crystal structure of Cpf1 in complex with CRISPR RNA.
111 X-ray crystal structures of the human serotonin transporter (SERT) bound to the antidepressants (S)-citalopram or paroxetine show that the antidepressants lock the protein in an outward-open conformation, and directly block serotonin from entering its binding site; the structures define the mechanism of antidepressant action in SERT and pave the way for future drug design.
110 Reconstitution, spectroscopy, and crystallography allow the construction of a model of the human nuclear pore.
109 Observing cellulose biosynthesis and membrane translocation in crystallo.
108 Structure of transcribing mammalian RNA polymerase II.
107 X-ray crystal structures of two distinct steps in the catalytic cycle of non-ribosomal peptide synthetases are described, offering the potential to generate novel products through engineering enzyme activity.
106 Structure of the voltage-gated calcium channel Cav1.1 complex.
105 Architecture of the mammalian mechanosensitive Piezo1 channel.